Heron Therapeutics
HRTX
#10254
Rank
โ‚น4.85 B
Marketcap
โ‚น25.51
Share price
-3.26%
Change (1 day)
-74.28%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2026 (TTM): -โ‚น17.27

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น17.75. In 2025 the company made an earnings per share (EPS) of -โ‚น11.21 a decrease over its 2024 EPS that were of -โ‚น8.41.

EPS history for Heron Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น17.2753.99%
2025-โ‚น11.2133.33%
2024-โ‚น8.41
2022-โ‚น161.65-23.11%
2021-โ‚น210.24-10%
2020-โ‚น233.60-0%
2019-โ‚น233.601.21%
2018-โ‚น230.80
2016-โ‚น425.1554.76%
2015-โ‚น274.711.73%
2014-โ‚น270.04-16.23%
2013-โ‚น322.3791.67%
2012-โ‚น168.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
SurModics
SRDX
-โ‚น114.93 547.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
โ‚น32.70-284.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น242.01-1,463.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
-โ‚น0.0000000000-100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Nektar Therapeutics
NKTR
-โ‚น626.05 3,426.32%๐Ÿ‡บ๐Ÿ‡ธ USA